Subtopic Deep Dive
Endolymphatic Sac Tumors
Research Guide
What is Endolymphatic Sac Tumors?
Endolymphatic sac tumors (ELSTs) are rare, locally aggressive papillary tumors of the temporal bone often associated with von Hippel-Lindau (VHL) disease, presenting with hearing loss and vestibulopathy.
ELSTs originate in the endolymphatic sac and cause irreversible hearing loss. They occur sporadically but link strongly to VHL germline mutations (Manski et al., 1997; 202 citations; Megerian et al., 1995; 158 citations). Over 10 key papers since 1995 detail histopathology, natural history, and surgical outcomes.
Why It Matters
ELST research guides surgical resection to preserve hearing in VHL patients, as shown in Kim et al. (2012; 64 citations) reporting outcomes from consecutive resections. Lonser et al. (2014; 195 citations) define natural history of VHL-associated CNS tumors including ELSTs, informing surveillance protocols. Binderup et al. (2022; 129 citations) update VHL guidelines emphasizing ELST screening, reducing morbidity from delayed diagnosis.
Key Research Challenges
Early Diagnosis Detection
ELSTs mimic other temporal bone lesions, delaying diagnosis until advanced hearing loss occurs (Megerian et al., 1995). Imaging protocols lack specificity for VHL association (Kim et al., 2005; 80 citations). Histopathologic confirmation remains essential but invasive.
Hearing Preservation Surgery
Tumors invade labyrinthine structures, risking total deafness during resection (Kim et al., 2012). Surgical approaches balance tumor control and auditory function (Choo et al., 2004; 103 citations). Long-term vestibulopathy persists post-surgery.
VHL Genetic Surveillance
ELSTs signal VHL predisposition, requiring lifelong screening for multi-organ tumors (Binderup et al., 2022). Natural history varies, complicating intervention timing (Lonser et al., 2014). Genetic counseling integrates ELST findings with hemangioblastoma risks.
Essential Papers
Endolymphatic Sac Tumors
Thomas J. Manski · 1997 · JAMA · 202 citations
<h3>Objectives.</h3> —Isolated reports suggest a possible association of endolymphatic sac tumors (ELSTs), which are extremely rare in the general population, with von Hippel-Lindau disease (VHL). ...
Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease
Russell R. Lonser, John A. Butman, Kristin Huntoon et al. · 2014 · Journal of neurosurgery · 195 citations
Object The tumors most frequently associated with von Hippel-Lindau (VHL) disease are hemangioblastomas. While they are associated with significant neurological impairment and mortality, their natu...
Endolymphatic sac tumors: Histopathologic confirmation, clinical characterization, and implication in von hippel‐lindau disease
Cliff A. Megerian, Michael J. McKenna, Roger C. Nuss et al. · 1995 · The Laryngoscope · 158 citations
Abstract The term “endolymphatic sac tumor” (ELST) was coined to identify the likely origin of aggressive papillary tumors of the temporal bone. To evaluate the validity of this designation, the te...
Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease
Richard J. Kahnoski, P. David, K Marsot-Dupuch et al. · 2000 · Neurosurgical Review · 155 citations
Neurologic Manifestations of von Hippel-Lindau Disease
John A. Butman · 2008 · JAMA · 131 citations
von Hippel-Lindau disease (VHL) is an autosomal-dominant neoplasia syndrome that is the result of a germline mutation of the VHL tumor suppressor gene on the short arm of chromosome 3. Patients wit...
von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance
Marie Louise Mølgaard Binderup, Maja Patricia Smerdel, Line Borgwadt et al. · 2022 · European Journal of Medical Genetics · 129 citations
von Hippel Lindau disease (vHL) is caused by a hereditary predisposition to multiple neoplasms, especially hemangioblastomas in the retina and CNS, renal cell carcinomas (RCC), pheochromocytomas, n...
Endolymphatic sac tumors in von Hippel—Lindau disease
Daniel Choo, Lawrence I. Shotland, Maryann Mastroianni et al. · 2004 · Journal of neurosurgery · 103 citations
Object. Von Hippel—Lindau (VHL) disease is a hereditary multiple-neoplasia syndrome mapping to chromosome 3p25–26. Endolymphatic sac (ELS) tumors have been identified as a neoplastic manifestation ...
Reading Guide
Foundational Papers
Start with Manski et al. (1997; 202 citations) for VHL-ELST association and Megerian et al. (1995; 158 citations) for histopathologic origin confirmation, as they establish core clinical-genetic links.
Recent Advances
Study Kim et al. (2012; 64 citations) for surgical results and Binderup et al. (2022; 129 citations) for updated VHL surveillance including ELSTs.
Core Methods
Core techniques include MRI for diagnosis (Kim et al., 2005), microsurgical resection via translabyrinthine approach (Kim et al., 2012), and VHL germline sequencing (Lonser et al., 2014).
How PapersFlow Helps You Research Endolymphatic Sac Tumors
Discover & Search
Research Agent uses searchPapers and citationGraph on 'Endolymphatic Sac Tumors' to map 202-citation Manski et al. (1997) as central node linking to VHL papers like Lonser et al. (2014; 195 citations). exaSearch uncovers sparse ELST case series; findSimilarPapers expands to temporal bone tumors.
Analyze & Verify
Analysis Agent applies readPaperContent to extract histopathology from Megerian et al. (1995), then verifyResponse with CoVe checks VHL-ELST association against Kim et al. (2005). runPythonAnalysis processes hearing loss data from Choo et al. (2004) for survival curves; GRADE grades surgical evidence as moderate.
Synthesize & Write
Synthesis Agent detects gaps in post-resection hearing data across Kim et al. (2012) and Choo et al. (2004), flagging contradictions in VHL penetrance. Writing Agent uses latexEditText for surgical protocol drafts, latexSyncCitations for 10-paper bibliography, latexCompile for review-ready manuscript, and exportMermaid for VHL tumor progression diagrams.
Use Cases
"Analyze hearing preservation rates in ELST surgeries from VHL patients"
Research Agent → searchPapers('ELST surgery hearing') → Analysis Agent → runPythonAnalysis(pandas on extracted audiometry data from Kim et al. 2012, Choo et al. 2004) → statistical summary with p-values and Kaplan-Meier plots.
"Draft LaTeX review on ELST natural history in VHL"
Synthesis Agent → gap detection across Lonser 2014, Manski 1997 → Writing Agent → latexEditText(structured sections), latexSyncCitations(10 VHL papers), latexCompile(PDF) → formatted review with ELST surveillance table.
"Find analysis code for VHL tumor growth models"
Research Agent → paperExtractUrls('VHL ELST growth') → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for hemangioblastoma volumetrics adaptable to ELSTs from Lonser et al. 2014 data.
Automated Workflows
Deep Research workflow scans 50+ VHL papers via searchPapers, structures ELST surveillance report with GRADE grading from Analysis Agent. DeepScan's 7-step chain verifies histopathology claims in Megerian et al. (1995) using CoVe against Kim et al. (2005). Theorizer generates hypotheses on ELST growth rates from natural history data in Lonser et al. (2014).
Frequently Asked Questions
What defines an endolymphatic sac tumor?
ELSTs are papillary tumors of the temporal bone endolymphatic sac, confirmed histopathologically with VHL association in 10-20% of sporadic cases (Megerian et al., 1995).
What are main diagnostic methods for ELSTs?
MRI shows destructive temporal bone mass with cisternographic enhancement; histopathology reveals papillary-cystic architecture (Kim et al., 2005). VHL genetic testing confirms syndrome association.
What are key papers on ELSTs?
Manski et al. (1997; 202 citations) links ELSTs to VHL; Megerian et al. (1995; 158 citations) provides histopathologic validation; Kim et al. (2012; 64 citations) details surgical outcomes.
What open problems exist in ELST research?
Optimal surgical timing for hearing preservation and non-surgical VHL-ELST management remain unresolved; long-term data on recurrence post-resection is limited (Choo et al., 2004).
Research Ear and Head Tumors with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Endolymphatic Sac Tumors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Ear and Head Tumors Research Guide